Errata-Therapeutic Choices
Errors and their corrections for CPhA's Compendium of Therapeutic Choices.
CTC 2019
Correction in Chapter 4: Bipolar Disorder, p. 65
- Table 5, under Third-line, asenapine should not appear. The correct list of drugs is:
- aripiprazole plus lamotrigine
- adjunctive clozapine
- adjunctive gabapentin
- olanzapine plus fluoxetine
Correction in Chapter 32: Diabetes Mellitus, p. 499
- Table 8, for lixisenatide, dosage should read, “Initial: 0.01 mg once daily SC for 14 days; Increase to 0.02 mg once daily SC on day 15”
Correction in Chapter 38: Heart Failure, p. 599
- Under Decompensated Heart Failure, the final sentence of the third paragraph should read, “According to current guidelines, some patients in a hypervolemic, hyponatremic state may benefit from the short-term use of the vasopressin antagonist tolvaptan to improve serum sodium concentration and cognitive symptoms.[2]”
Correction in Chapter 63: Irritable Bowel Syndrome, p. 976
- Table 4, for pinaverium, comments should read, “To minimize esophageal irritation, take with a glass of water and food, do not chew or crush, do not lie down after administration.”
CTC 2017
Correction in Chapter 38: Dyslipidemias, p. 538
- Table 7 for cholestyramine, in Drug Interactions, it should read, “Administer other drugs 1 h before or 4-6 h after resin to limit possible reduced absorption in the GI tract.”